Form 8-K · Current report
Clorox 8-K, filed Nov 2, 2026
- Filed
- CIK
- 0000021076
- Accession no.
- 0000021076-26-000044
Summary
Clorox reported first-quarter fiscal 2027 net sales of $1.91 billion, up 33%, and adjusted EPS of $1.55, up 82%, while maintaining its fiscal 2027 sales and adjusted EPS outlook ranges and saying adjusted EPS is expected closer to the low end due to higher input-cost inflation. Chair and CEO Linda Rendle said the cost environment has become more challenging and that Clorox is integrating GOJO to support Clorox Purell ProCare.
Key points
- Clorox first-quarter fiscal 2027 net sales increased 33% to $1.91 billion, with organic sales up 18%.
- Gross margin decreased 130 basis points to 40.4%, while adjusted EPS increased 82% to $1.55.
- Clorox maintained its fiscal 2027 net sales and adjusted EPS outlook ranges but said adjusted EPS is expected closer to the low end, with gross margin now expected at about 41.5%.
- Clorox launched Clorox Purell ProCare, bringing together CloroxPro and GOJO with a unified sales and service organization.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On November 2, 2026, The Clorox Company issued a press release announcing its financial results for its first quarter ended September 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 7.01 Regulation FD Disclosure Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information. Item 9.01 Financial Statements and Exhibits (d) Exhibits See the Exhibit Index below. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.